Skip to content
The Nexus
DossierENTITY

biologics

Coverage of biologics in the Nexus archive.

Earliest in view: Jun 12 · 21:45 UTCMost recent: Jun 12 · 21:45 UTC
Co-mentioned in this coverage
Trump administrationorganization1Centers for Medicare and Medicaid Servicesorganization1Medicareorganization1Food and Drug Administrationorganization1drugmakerstopic1
Recent coverage
  • HEALTHJun 12 · 21:45 UTCSTAT NEWS
    STAT+: Trump administration revisits policy to close Medicare drug price negotiation loophole

    The Trump administration proposed a policy to prevent drugmakers from evading Medicare price negotiations by adding active ingredients to drugs. The policy aims to finalize the selection of 20 drugs and biologics for negotiation by February 1, 2027, with negotiated prices taking effect in 2029. Medicare typically waits 7 to 11 years after FDA approval before negotiating prices, with biologics requiring longer delays.

biologics · Dossier · The Nexus